Tong Ren Tang Technologies Co., Ltd. is a pharmaceutical company based in China with a high-risk ESG score of 30.1. The company specializes in the production and distribution of Chinese medicine, operating primarily in Mainland China and Hong Kong. With a focus on sustainability and governance, Tong Ren Tang Technologies is known for its manufacture and sale of Chinese medicine products and healthcare items. Additionally, the company provides Chinese medical consultations and treatments worldwide.